Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

57 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
68Ga-DOTA-TOC Uptake in Pleomorphic Adenoma.
Laurens ST, Netea-Maier RT, Aarntzen EJHG. Laurens ST, et al. Among authors: aarntzen ejhg. Clin Nucl Med. 2018 Jul;43(7):524-525. doi: 10.1097/RLU.0000000000002133. Clin Nucl Med. 2018. PMID: 29847321
Succinylated Gelatin Improves the Theranostic Potential of Radiolabeled Exendin-4 in Insulinoma Patients.
Buitinga M, Jansen T, van der Kroon I, Woliner-van der Weg W, Boss M, Janssen M, Aarntzen E, Béhé M, Wild D, Visser E, Brom M, Gotthardt M. Buitinga M, et al. J Nucl Med. 2019 Jun;60(6):812-816. doi: 10.2967/jnumed.118.219980. Epub 2018 Nov 30. J Nucl Med. 2019. PMID: 30504139
18F-FDG PET/CT-Guided Treatment Duration in Patients with High-Risk Staphylococcus Aureus Bacteremia: A Proof of Principle.
Berrevoets MAH, Kouijzer IJE, Slieker K, Aarntzen EHJG, Kullberg BJ, Oever JT, Bleeker-Rovers CP. Berrevoets MAH, et al. J Nucl Med. 2019 Jul;60(7):998-1002. doi: 10.2967/jnumed.118.221929. Epub 2018 Dec 14. J Nucl Med. 2019. PMID: 30552202
Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm.
Grootjans W, Kok P, Butter J, Aarntzen E. Grootjans W, et al. J Vis Exp. 2020 Jul 23;(161). doi: 10.3791/60258. J Vis Exp. 2020. PMID: 32773757
[18F]FDG PET/CT in the staging of inflammatory breast cancer: A systematic review.
van Uden DJP, Prins MW, Siesling S, de Wilt JHW, Blanken-Peeters CFJM, Aarntzen EHJG. van Uden DJP, et al. Among authors: aarntzen ehjg. Crit Rev Oncol Hematol. 2020 Jul;151:102943. doi: 10.1016/j.critrevonc.2020.102943. Epub 2020 May 7. Crit Rev Oncol Hematol. 2020. PMID: 32416347
Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CT.
Lobeek D, Rijpkema M, Terry SYA, Molkenboer-Kuenen JDM, Joosten L, van Genugten EAJ, van Engen-van Grunsven ACH, Kaanders JHAM, Pegge SAH, Boerman OC, Weijs WLJ, Merkx MAW, van Herpen CML, Takes RP, Aarntzen EHJG, Oyen WJG. Lobeek D, et al. Among authors: aarntzen ehjg. Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2647-2655. doi: 10.1007/s00259-020-04766-2. Epub 2020 Mar 20. Eur J Nucl Med Mol Imaging. 2020. PMID: 32198613 Free PMC article.
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial.
Boudewijns S, Bloemendal M, de Haas N, Westdorp H, Bol KF, Schreibelt G, Aarntzen EHJG, Lesterhuis WJ, Gorris MAJ, Croockewit A, van der Woude LL, van Rossum MM, Welzen M, de Goede A, Hato SV, van der Graaf WTA, Punt CJA, Koornstra RHT, Gerritsen WR, Figdor CG, de Vries IJM. Boudewijns S, et al. Among authors: aarntzen ehjg. Cancer Immunol Immunother. 2020 Mar;69(3):477-488. doi: 10.1007/s00262-019-02466-x. Epub 2020 Jan 24. Cancer Immunol Immunother. 2020. PMID: 31980913 Free PMC article. Clinical Trial.
Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism.
van der Heijden CDCC, Smeets EMM, Aarntzen EHJG, Noz MP, Monajemi H, Kersten S, Kaffa C, Hoischen A, Deinum J, Joosten LAB, Netea MG, Riksen NP. van der Heijden CDCC, et al. Among authors: aarntzen ehjg. J Clin Endocrinol Metab. 2020 May 1;105(5):e1967-80. doi: 10.1210/clinem/dgz306. J Clin Endocrinol Metab. 2020. PMID: 31875423 Free PMC article.
Programmed Cell Death-1/Ligand-1 PET Imaging: A Novel Tool to Optimize Immunotherapy?
Verhoeff SR, van den Heuvel MM, van Herpen CML, Piet B, Aarntzen EHJG, Heskamp S. Verhoeff SR, et al. Among authors: aarntzen ehjg. PET Clin. 2020 Jan;15(1):35-43. doi: 10.1016/j.cpet.2019.08.008. Epub 2019 Oct 29. PET Clin. 2020. PMID: 31735300 Free article. Review.
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer.
Westdorp H, Creemers JHA, van Oort IM, Schreibelt G, Gorris MAJ, Mehra N, Simons M, de Goede AL, van Rossum MM, Croockewit AJ, Figdor CG, Witjes JA, Aarntzen EHJG, Mus RDM, Brüning M, Petry K, Gotthardt M, Barentsz JO, de Vries IJM, Gerritsen WR. Westdorp H, et al. Among authors: aarntzen ehjg. J Immunother Cancer. 2019 Nov 14;7(1):302. doi: 10.1186/s40425-019-0787-6. J Immunother Cancer. 2019. PMID: 31727154 Free PMC article. Clinical Trial.
57 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback